UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (date of earliest event reported): December 16, 2012

                                DNA BRANDS, INC.
             (Exact name of registrant as specified in its charter)

    Colorado                          000-53086                   26-0394476
--------------------            ---------------------        ------------------
(State or other jurisdiction    (Commission File No.)        (IRS Employer
of incorporation)                                            Identification No.)

                              506 N.W. 77th Street
                           Boca Raton, Florida, 33487
                  --------------------------------------------
          (Address of principal executive offices, including Zip Code)


       Registrant's telephone number, including area code: (954) 978-8401


                                       N/A
                   -----------------------------------------
          (Former name or former address if changed since last report)


Check appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy  the filing  obligation  of the  registrant  under any of the  following
provisions (see General Instruction A.2. below)

[] Written communications  pursuant to Rule 425 under the Securities Act (17 CFR
   230.425)

[] Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
   240.14a-12)

[] Pre-commencement  communications pursuant to Rule 14d-2(b) under the Exchange
   Act (17 CFR 240.14d-2(b))

[] Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange
   Act (17 CFR 240.13e-4(c))

                                       1


Item 3.02.  Unregistered Sales of Equity Securities

     Between  December  16, 2012 and April 16, 2013 the Company  sold  3,199,999
shares of its common stock to private investors.

     The Company  relied  upon the  exemption  provided  by Section  4(2) of the
Securities  Act of 1933 in  connection  with the issuance of these  shares.  The
persons who acquired these shares were sophisticated investors and were provided
full information  regarding the Company's business and operations.  There was no
general  solicitation in connection with the offer or sale of these  securities.
The persons who acquired these shares acquired them for their own accounts.  The
certificates  representing  these shares will bear a restricted legend providing
that they cannot be sold except pursuant to an effective  registration statement
or an  exemption  from  registration.  No  commission  was paid to any person in
connection with the issuance of these shares.

                                       2

                                   SIGNATURES


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.


Date:  April 16, 2013

                                DNA BRANDS, INC.


                                    By: /s/ Darren M. Marks
                                        --------------------------
                                        Darren M. Marks, President